1Sjogren F, Davidsson K, Sjostrom M, et al. Cutaneous microdial- ysis: cytokine evidence for altered innate reactivity in the skill of psoriasis patients? [J]. AAPS J, 2012, 14(2): 187-195.
3Egesi A, Sun G, Khaehemoune A, et al. Statins in skin: re- search and rediscovery, from psoriasis to sclerosis [J]. J Drugs Dermatol, 2010, 9(8): 921-927.
4Spuls PI, Lecluse LL, Poulsen ML, et al. How good are elinical severity and outcome measures for psoriasis?: quantitative evalua- tion in a systematic review[J]. J Invest Dermatol, 2010, 130(4): 933-943.
5Diamantino F, Ferreira A. Future perspectives in the treatment of psoriasis: news in biological therapies [J].Acta Med Port, 2011, 24(6): 997-1004.
6Fink AM, Cauza E, Hassfeld W, et al. Vascular endothelial growth factor in patients with psoriatic arthritis[J]. Clin Exp Rheumatol, 2007, 25(2): 305-308.
7Coimbra S, Figueiredo A, Castro E, et al. The roles of cells and cytokines in the pathogenesis of psoriasis [J]. Int J Dermatol, 2012, 51(4): 389-395.
8Zaba LC, Fuentes-Duculan J, Eungdamrong N J, et al. Psoriasis is characterized by accumulation of immunostimulatory and Thll Thl7 cell-polarizing myetoid dendritic: cells[J]. J Invest Derma- tol, 2009, 129(1): 79-88.
9Nanba T, Watanabe M, lnoue N, et al. Increases of the Thl/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Thl7 cells in intractable Graves' disease[J]. Thyroid, 2009, 19 (5): 495-501.
10Kagami S, Rizzo HL, Lee JJ, et al. Circulating Thl7, Th22, anti Thl cells are increased in psoriasis[J]. J Invest Dermatol, 2010, 130(5): 1373-1383.
4Meyer-Hoffert U, Wingertszahn J, Wiedow O. Human leukocyte elastase induces keratinoeyte proliferation by epidermal growth factor receptor activation[J]. J Invest Dermatol, 2004, 123 ( 2 ) : 338-345.
5MacDonald N, Cumberhatch M, Singh M, et al. Proteomic analysis of suction blister fluid isolated from human skin[J]. Clin Exp Dermatol, 2006, 31 (3) : 445-448.
6Horwitz M, Duan Z, Korkmaz B, et al.Neutrophil elastase in cyclic and severe congenital neutropenia[J].Blood, 2007, 109 ( 8 ) : 1817-1824.
8K.K. Park,J.J. Wu,J. Koo.A randomized, ‘head‐to‐head’ pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB‐UVB) phototherapy in obese psoriasis patients[J]. Journal of the European Academy of Dermatology and Venereology . 2013 (7)
9Susana Coimbra,Hugo Oliveira,Luís Belo,Américo Figueiredo,Petronila Rocha-Pereira,Alice Santos-Silva.Principal Determinants of the Length of Remission of Psoriasis Vulgaris After Topical, NB-UVB, and PUVA Therapy[J]. American Journal of Clinical Dermatology . 2013 (1)
